Publisher
Springer International Publishing
Reference49 articles.
1. Shah PB, Welt FG, Mahmud E, Phillips A, Kleiman NS, Young MN, Sherwood M, Batchelor W, Wang DD, Davidson L, Wyman J. Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: an ACC/SCAI position statement. Cardiovasc Interv. 2020;13(12):1484–8.
2. Virani SA, Clarke B, Ducharme A, Ezekowitz JA, Heckman GA, McDonald M, Mielniczuk LM, Swiggum E, Van Spall HG, Zieroth S, Society CHF. Optimizing access to heart failure care in Canada during the COVID-19 pandemic. Can J Cardiol. 2020;36(7):1148–51.
3. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, Ma K, Xu D, Yu H, Wang H, Wang T, Guo W, Chen J, Ding C, Zhang X, Huang J, Han M, Li S, Luo X, Zhao J, Ning Q. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. https://doi.org/10.1136/bmj.m1091. Erratum in: BMJ. 2020;368:m1295. PubMed PMID: 32217556.
4. Zhou F, Yu T, Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020.
5. Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med. 2020;382(25):e102.